Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GM.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GM.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GM.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FU.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used